REDUCEDT+30
Amylyx Pharmaceuticals Inc · NASDAQ
−29,025 sh · $932.6K
Filed 14 Sept 2026SEC Form 4view source
- REDUCEDT+30
Amylyx Pharmaceuticals Inc · NASDAQ
−1,439 sh · $47.7K
Filed 14 Sept 2026SEC Form 4view source - ACQUIREDStale
Amylyx Pharmaceuticals Inc · NASDAQ
+60,039 sh
Filed 20 Aug 2026SEC Form 4view source